Related Experiment Video

Updated: Jun 30, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendations

Şükrü Hatun1,2, Tuğba Gökçe1, Ecem Can1

  • 1Koç University Hospital, Department of Pediatric Endocrinology and Diabetes, İstanbul, Turkey

Journal of Clinical Research in Pediatric Endocrinology
|March 15, 2024
PubMed

Insights

Effective type 1 diabetes (T1D) management requires a holistic approach, integrating optimal glycemic control with quality of life. This review highlights 10 key recommendations from ISPAD 2018-2022 guidelines for practical T1D care.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Pediatric Diabetes Care

Background:

  • Type 1 diabetes (T1D) management necessitates a comprehensive strategy beyond glycemic control.
  • Current goals include optimizing glucose levels, enhancing quality of life, and preventing complications.

Purpose of the Study:

  • To present 10 key recommendations for practical T1D management based on ISPAD 2018-2022 guidelines.
  • To emphasize the role of teamwork and technology in current T1D treatment.

Main Methods:

  • Review of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines from 2018-2022.
  • Integration of clinical experiences to derive practical recommendations.

Main Results:

  • The review synthesizes 10 critical recommendations for T1D management.
  • Emphasis is placed on a holistic approach, including psychosocial aspects and long-term health.

Conclusions:

  • Adherence to updated ISPAD guidelines and adoption of technology are crucial for optimal T1D outcomes.
  • Teamwork and tailored guidance are essential for individuals with T1D and their families.

Keywords:
Carbohydrate countingdiabetes campglucose targetHbA1cinsulin carbohydrate ratioinsulin sensitivityglycemic outcome

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.8K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
281
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
533
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
259